Financed Projects

Ongoing Financed Projects

EvaMobs: Evolvable and rapidly adaptable monobodies: a broad-spectrum antiviral platform – Horizon Europe HORIZON-HLTH-2023-DISEASE-03-04, ID 101137419, start Jan 2024; Cláudio M. Soares – PI; Diana Lousa – co-PI.
The BioPlaTTAR Platform for the Tailored and Rapid Development of Antiviral
Biopharmaceuticals – La Caixa Foundation HR22-00722, Nov 2022-Oct 2025, Cláudio M. Soares – PI; Diana Lousa – co-PI.
PI3K / AKT / mTOR pathway modulation as target therapy in the treatment of breast and colorectal cancer – FCT/CAPES (2019.00199.CBM) “”. 2020-2024 Cláudio M. Soares – PI in Portugal

Design of protein chimeras targeting SARS-CoV-2 – FCT FCT/CPCA/A0/7305/2020 Advanced Computation proposal in Bob | Minho Advanced Computing Centre. 2020-2021 – Diana Lousa – PI
Predicting SARS-CoV-2 susceptibility by tracking the genetic variability of the ACE2 receptor – FCT RESEARCH4COVID 19 (2nd edition) – 2020 – Members of team.
A practical assay for routine detection of neutralizing antibodies against SARS-CoV-2 that bypasses requirements for high biosafety laboratory usage – FCT RESEARCH4COVID 19 (2nd edition) – 2020 – Members of team.
SHIKIFACTORY100 – Modular cell factories for the production of 100 compounds from the shikimate pathway – H2020-NMBP-BIO-2018 – 2019-2023 – Members of team.
Using computational and experimental methods to provide a global characterization of viral fusion peptides – PTDC/CCI-BIO/28200/2017 – 2019-2022 – Diana Lousa – PI
Characterization of maltose translocation in the MalFGK2E transporter – European PRACE Preparatory Access Proposal 2010PA4247– 2017 – Cláudio M. Soares – PI
Probing the pH-induced conformational change of influenza haemaggglutinin using micro-second long simulations – European PRACE Preparatory Access Proposal 2010PA3220 – 2016 – Cláudio M. Soares – PI
Engineering a highly active NiFeSe Hydrogenase for electrocatalytic and photocatalytic applications – PTDC/BBB-BEP/2885/2014 entitled – 2016-2018 – Members of team.